Atlas Trials

A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy II

Clinical trial NCT04596540 · COMPLETED

Trial details

NCT number
NCT04596540
Sponsor
Swedish Orphan Biovitrum
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Gout
Start date
2020-11-30
Primary completion
2023-01-10
Enrollment
153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.